IgG Binding Protein LT for Safety Evaluation
What You Need to Know Before You Apply
What is the purpose of this trial?
This study evaluates the safety and tolerability of the food ingredient IgG Binding Protein LT (BP-LT) when added to a daily diet. BP-LT is a stable protein ingredient being functional in the gastrointestinal tract and without systemic absorption. This registration covers a decentralized, randomized, double-blind, placebo-controlled clinical study evaluating BP-LT in healthy adults.
Who Is on the Research Team?
Ashley Mateus, Ph.D
Principal Investigator
People Science, In.c.
Are You a Good Fit for This Trial?
This trial is for healthy adults who want to help test the safety of a new food ingredient. People with health problems or certain conditions may not be able to join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- IgG Binding Protein LT
Trial Overview
The study tests a new protein ingredient called IgG Binding Protein LT (BP-LT) added to the daily diet, compared to a placebo. Participants are randomly assigned and neither they nor researchers know which group they're in.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Received test product containing IgG Binding Protein LT
Received Placebo product without IgG Binding Protein LT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Bactolife A/S
Lead Sponsor
People Science, Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.